World’s First Microbiome Fund Swells to €160M With Major Pharma Also Chipping In
The French VC firm Seventure's Health for Life Capital investment fund for Microbiome and Biotech…
The potential of the microbiome to be used for the development of promising therapeutics and diagnostic approaches has spurred a hype around this emerging field. Over the last decade, researchers have found correlations between the human microbiome and a number of diseases, including inflammatory bowel disease, diabetes, autoimmune diseases, cancer, depression, and many more. As the number of clinical trials grows, investor interest is increasing.
Read on to find out more about the flourishing microbiome field and how it shows promise for the treatment of a large variety of diseases.
Beyond the Gut: An Atlas of the Human Microbiome
This report discusses the role of the gut and blood microbiomes in different diseases and how they can be used for biomarker discovery and for the development of therapeutics.
Go to ReportThe French VC firm Seventure's Health for Life Capital investment fund for Microbiome and Biotech…
The Microbiome and Immuno-Oncology fields are hugely trendy in the Biotech Industry - and now…
Monellin chain B is an artificial sweetener initially mistaken for a carbohydrate. It has since…
This week we've left the sunny Portuguese coast behind us and arrived in the 'City…
BioGaia is a leading microbiome biotech from Stockholm (Sweden) who use the beneficial bacterium Lactobacillus…
A method of profiling bacterial growth time in the gut's microbiome has been shown to…
Hi there! Here are the 5 most important Biotech things that happened outside Europe in…
Antibiotic resistance is a public health problem worldwide. According to WHO, by 2050, over 10 million…
IntegraGen and the Institut Pasteur signed an agreement for high-throughput sequencing in the field of…
Microbiomics is one of the next big trends in the Biotech industry. Using bacteria present in…
Evotec AG and Second Genome decided to collaborate in small molecule-based discovery and development activities…
4D Pharma, a biopharmaceutical company focusing on significant new therapeutic areas, plan to raise €46M…